Skip to main content

AgoraSign in

Andrew Gounardes

Sponsor · State Senator, District 26 · Democratic

Follow

Senate bill · S8334 (2025-26)

Relates to insurance reimbursement for vaccination for severe acute respiratory syndrome coronavirus 2

Latest action Mar 18, 2026

Summary

Requires insurance reimbursement for vaccination for severe acute respiratory syndrome coronavirus 2.

Your position on this bill

Not chosen yet

Sign in to choose

Where it stands

Passed one of the two chambers; it still needs the other.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

New York State Senate

Same as A8824, the matching bill in the Assembly.

Amends the Insurance Law.

Committee

Insurance · New York State Assembly

Also referred to Insurance · New York State Senate, Rules · New York State Assembly, Rules · New York State Senate.

Purpose, from the sponsor's memo

This bill would include vaccines against SARS CoVID-2 virus on the list of vaccines which the Commissioner of Insurance must mandate for cover- age by health insurance providers within the State of New York and Include vaccines against SARS CoVID-2 virus on on the list of what Medi- caid must cover for an enrollee who receives such a vaccine at a pharma- cy

Filed with the bill. Read it on nysenate.gov (opens in a new tab)

Recorded votes

  • Vote: Floor vote

    NY SenateMar 4, 2026Result: passed

    (46) (14) (0) (3)
  • Vote: Committee vote · Insurance

    Senate InsuranceFeb 9, 2026Result: passed

    (10) (1) (0) (0)
  • Vote: Floor vote

    NY SenateJun 9, 2025Result: passed

    (53) (9) (0) (1)
  • Vote: Committee vote · Rules

    Senate RulesJun 9, 2025Result: passed

    (19) (2) (0) (0)

The sponsor's argument

Why Andrew Gounardes says this is needed

In light of recent and conflicting guidance from the U.S. Department of Health and Human Services (HHS)-which has modified its COVID-19 vaccine recommendations by no longer advising routine vaccination for healthy children and pregnant individuals-it is imperative for New York State to enact legislation that ensures health insurance providers continue to cover the COVID-19 vaccine. This mixed messaging from federal health authorities risks undermining public confidence and access, making it all the more essential for the state to step in to safeguard public health, maintain equitable vaccine access, and uphold its commitment to preventive care. Despite the HHS's updated stance, COVID-19 continues to pose significant health risks. Children, while generally experiencing milder symptoms, can still suffer severe outcomes and contribute to community trans- mission. Pregnant individuals face increased risks of complications from COVID-19, and vaccination has been shown to confer protective benefits to both mothers and their infants. State-level legislation ensuring vaccine coverage reinforces New York's proactive approach to mitigating these risks and protecting vulnerable populations. The HHS's decision may lead to inconsistencies in vaccine availability and coverage across states. By proactively legislating insurance cover- age for the COVID-19 vaccine, New York can preempt potential gaps resulting from reduced federal support, ensuring continuity in vaccine access and public health initiatives. State legislation mandating insurance coverage for COVID-19 vaccines can bolster public confidence in vaccination programs. It sends a clear message about the state's trust in the safety and efficacy of vaccines, countering potential misinformation and hesitancy that may arise from changing federal guidelines. In response to the HHS's revised COVID-19 vaccine recommendations, it is crucial for New York State to enact legislation that mandates health insurance coverage for the vaccine. Such action will ensure equitable access, protect public health, uphold preventive healthcare standards, address potential federal support gaps, and reinforce public confidence in vaccination efforts. By taking this step, New York reaffirms its commitment to the health and well-being of all its residents.

This is the sponsor's own case for the bill, quoted from their memorandum. It is not Agora's description of what the bill does.

Full history

  1. Mar 18, 2026

    Amend and Recommit to Insurance

    AMEND AND RECOMMIT TO INSURANCE

    NY Assembly

  2. Mar 4, 2026

    Sent to the executive

    DELIVERED TO ASSEMBLY

    NY Senate

  3. Mar 4, 2026

    Passed a chamber

    PASSED SENATE

    NY Senate

  4. Mar 4, 2026

    Referred to committee

    REFERRED TO INSURANCE

    NY Assembly

  5. Feb 24, 2026

    Amended

    AMENDED ON THIRD READING 8334A

    NY Senate

Show full history (11 earlier events)
  1. Feb 11, 2026

    Advanced to Third Reading

    ADVANCED TO THIRD READING

    NY Senate

  2. Feb 10, 2026

    2ND Report CAL.

    2ND REPORT CAL.

    NY Senate

  3. Feb 9, 2026

    1ST Report CAL.301

    1ST REPORT CAL.301

    NY Senate

  4. Jan 7, 2026

    Died in Assembly

    DIED IN ASSEMBLY

    NY Assembly

  5. Jan 7, 2026

    Referred to committee

    REFERRED TO INSURANCE

    NY Senate

  6. Jan 7, 2026

    Referred to committee

    REFERRED TO INSURANCE

    NY Assembly

  7. Jun 9, 2025

    Sent to the executive

    DELIVERED TO ASSEMBLY

    NY Senate

  8. Jun 9, 2025

    Ordered to Third Reading CAL.1724

    ORDERED TO THIRD READING CAL.1724

    NY Senate

  9. Jun 9, 2025

    Passed a chamber

    PASSED SENATE

    NY Senate

  10. Jun 9, 2025

    Referred to committee

    REFERRED TO INSURANCE

    NY Assembly

  11. Jun 3, 2025

    Referred to committee

    REFERRED TO RULES

    NY Senate

About this record

Summary

The summary comes from NY Open Legislation, the New York State Senate's public record. For more, see How we handle summaries.

Cosponsors

The list shows the cosponsors who are on Agora, A to Z. The official record may list more.

Party colors

Parties are shown in the same neutral colors.

Source

From NY Open Legislation, the NY Senate and Assembly, and official rosters. This record was last updated Nov 3, 2026. About our data

Read the record

Follow